请输入您要查询的百科知识：

　

词条 Cochlear Limited
释义

  1. Products

  2. Corporate Affairs

  3. References

  4. See also

{{Use Australian English|date=June 2013}}{{Use dmy dates|date=June 2013}}{{Infobox company
| name = Cochlear Limited
| logo = Cochlear logo new.png
| type = Public
| traded_as = {{asx|COH}}
| industry = Biotechnology
| foundation = 1981
| location = Sydney, Australia
| key_people = Dig Howitt (CEO)
Rick Holliday-Smith (Chairman)
| products = Cochlear implants
Bone-anchored hearing aids
Cochlear wireless accessories
Bone anchored prosthetics
| revenue = {{profit}} {{A$}}1240 million (2017) [1]
| profit = {{profit}} A$224 million (2017) [1]
| num_employees = 2,800 in 20 countries (2015)[1]
| homepage = www.cochlear.com
}}Cochlear ({{asx|COH}}) is a medical device company that designs, manufactures and supplies the Nucleus cochlear implant, the Hybrid electro-acoustic implant and the Baha bone conduction implant.[2]

Based in Sydney, Cochlear was formed in 1981 with finance from the Australian government to commercialise the implants pioneered by Dr Graeme Clark.[3][4] Today, the company holds over two-thirds of the worldwide hearing implant market,[5][6] with more than 250,000 people receiving one of Cochlear's implants since 1982.[2]

Cochlear was named Australia's most innovative company in 2002 and 2003,[7] and one of the world's most innovative companies by Forbes in 2011.[8]

Products

Cochlear produces three implants for different medical situations.

Nucleus is a system combining an electrical simulation device that is surgically implanted behind a patient's ear, a processor that captures sounds, and an electrode array that relays the sounds to the brain.[2][9] It is a direct descendant of the original cochlear implants, also known as Nucleus, developed by Dr Graeme Clark in Melbourne during the 1970s.[3] Nucleus was the first cochlear implant to be approved by the U.S. Food and Drug Administration.[10] The system is upgradable, for example by installing a new sound processor, without surgery.[2] Cochlear's latest processor, Nucleus 6, was launched in 2013 after six years of development.[11] It replaced the Nucleus 5 system. In 2011, the Nucleus 5 CI500 series internal implant was recalled[12] with up to a 24% failure rate.[13] In 2013, the Nucleus implant recorded 99% reliability over the last 8 years, more than any similar product.[14]

Hybrid is an electro-acoustic system combining a cochlear implant with an acoustic hearing aid, suitable for patients who have residual hearing at low frequencies.[15] The implant of the Hybrid system is a smaller variant of Nucleus, with an electrode that relays only high frequency sounds,[15] while the acoustic component amplifies low frequency sounds and transmits them to the brain through the ordinary nerve pathway.[2] Hybrid was launched in 2008 and won Australian Engineering Excellence and International Design Awards in 2009.[15]

Baha (derived from bone anchored hearing aid) is a bone conduction system involving a small titanium implant that is ossointegrated with the bone behind a patient's ear.[2] A sound processor captures sounds, which is passed to the implant and directly transferred to the inner ear through the skull.[2][16] Baha was originally produced by Swedish biotechnology group Entific Medical Systems before that company was acquired by Cochlear in 2005.[17]

Corporate Affairs

Cochlear manufactures principally in Sweden and Australia, including at a purpose-built facility at Macquarie University in Sydney.[18][19] The company's products are supplied to over 100 countries internationally, with 43% sales revenue ($403 million) derived from the Americas, 40% ($377.6 million) from Europe, the Middle East and Africa and 17% ($161.3 million) from the Asia-Pacific region as of 2015.[2] Cochlear spent $128 million on research and development in FY15.[2]

In 2011, reports arose of Nucleus model CI500 implants shutting down, although less than 1% of devices were affected and the failures posed no health risks.[20][21] Cochlear funded a complete recall of the model, with an older version of the Nucleus implant being available as a replacement.[20][21] The company spent $101.3 million on the recall.[22]

References

1. ^1 2 {{cite web|url=http://member.afraccess.com/media?id=CMN://2A1029797&filename=20170817/COH_01884665.pdf|format=PDF|title=2017 Cochlear Limited Annual Report}}
2. ^1 2 3 4 5 6 7 8 {{cite web|url=http://www.cochlear.com/wps/wcm/connect/df3dd08c-c209-4c05-826a-1507735f5069/en_corporate_annualreport2015_editorial_2.08mb.pdf?MOD=AJPERES&CONVERT_TO=url&CACHEID=df3dd08c-c209-4c05-826a-1507735f5069|publisher=Cochlear|title=Annual report 2015|accessdate=3 November 2015}}
3. ^1 {{cite web|url=http://www.powerhousemuseum.com/hsc/cochlear/history.htm|publisher=Powerhouse Museum|title=History: Who developed the cochlear implant and why?|accessdate=22 June 2013}}
4. ^{{cite web|url=http://www.cochlear.com/wps/wcm/connect/intl/about/company-information/history/history|publisher=Cochlear|title=History|accessdate=22 June 2013}}
5. ^{{cite web|url=https://www.reuters.com/article/2012/08/07/us-australia-cochlear-return-idUSBRE87604B20120807|publisher=Reuters|title=Australia's Cochlear plans to return implant to market|accessdate=22 June 2013}}
6. ^{{cite web|url=http://finance.ninemsn.com.au/newscolumnists/other/8605975/questions-mount-over-cochlears-top-status|publisher=9 News|title=Questions mount over Cochlear's top status|accessdate=22 June 2013}}
7. ^{{cite web|url=http://www.smh.com.au/articles/2003/11/17/1069027028526.html|publisher=Sydney Morning Herald|title=Cochlear named most innovative company|accessdate=22 June 2013}}
8. ^{{cite web|url=https://www.forbes.com/lists/2011/most-innovative-growth-companies.html|publisher=Forbes|title=Most innovative growth companies|accessdate=22 June 2013}}
9. ^{{cite web|url=http://www.powerhousemuseum.com/hsc/cochlear/the_cochlear.htm|publisher=Powerhouse Museum|title=The cochlear implant|accessdate=22 June 2013}}
10. ^{{cite web|url=http://www.asha.org/policy/TR2004-00041/#sec1.3.2|publisher=American Speech-Language-Hearing Association|title=Cochlear implants technical report|accessdate=22 June 2013}}
11. ^{{cite web|url=http://www.heraldsun.com.au/business/hearing-company-cochlear-stakes-growth-on-new-range/story-fni0dcne-1226656527466|publisher=Herald Sun|title=Hearing company Cochlear stakes growth on new range|accessdate=22 June 2013}}
12. ^{{cite web|url=https://www.wsj.com/articles/SB10001424053111904265504576565540894094816|publisher=Wall Street Journal|title=Cochlear Recalls Line of Ear Implants|accessdate=22 July 2016}}
13. ^{{cite web|url=https://www.researchgate.net/publication/236837222_Nucleus_N5_CI500_series_implant_recall_Hard_failure_rate_at_a_major_cochlear_implantation_center|work=The Laryngoscope|title=Nucleus N5 CI500 series implant recall: Hard failure rate at a major cochlear implantation center|publisher=Wiley|accessdate=22 June 2016}}
14. ^{{cite web|url=http://www.cochlear.com/wps/wcm/connect/intl/home/discover/cochlear-implants/the-nucleus-6-system-/nucleus-6-for-adults/cochlears-implant-portfolio/cochlear-nucleus-reliability-report-2013/cochlear-nucleus-reliability-report-2013|publisher=Cochlear|title=Cochlear Nucleus Reliability Report 2013|accessdate=22 June 2013}}
15. ^1 2 {{cite web|url=http://www.powerhousemuseum.com/collection/database/?irn=415633|publisher=Powerhouse Museum|title=Cochlear Hybrid hearing system 2008|accessdate=22 June 2013}}
16. ^{{cite web|url=http://umm.edu/programs/hearing/services/baha-implant|publisher=University of Maryland Medical Center|title=Baha implant|accessdate=22 June 2013}}
17. ^{{cite web|url=http://www.smh.com.au/news/Business/Cochlear-buys-into-Sweden/2005/03/04/1109700679546.html|publisher=Sydney Morning Herald|title=Cochlear buys into Sweden|accessdate=22 June 2013}}
18. ^{{cite web|url=http://www.biospectrumasia.com/biospectrum/analysis/2110/new-technologies-push-growth-cochlear#.UcVj4PkweaU|publisher=BioSpectrum Asia|title=New technologies push growth of Cochlear|accessdate=22 June 2013}}
19. ^{{cite web|url=http://www.smh.com.au/news/Business/Cochlear-well-placed-for-growth-trend/2007/10/23/1192941050067.html|publisher=Sydney Morning Herald|title=Cochlear 'well placed for growth trend'|accessdate=22 June 2013}}
20. ^1 {{cite web|url=http://www.news.com.au/business/hearing-aid-company-shares-drop-sharply-as-cochlear-recalls-product/story-e6frfm1i-1226134706887|publisher=News Limited|title=Hearing aid company's shares drop sharply as Cochlear recalls product|accessdate=22 June 2013}}
21. ^1 {{cite web|url=http://www.smh.com.au/business/cochlear-shares-plummet-on-product-recall-20110912-1k4sr.html|publisher=Sydney Morning Herald|title=Cochlear shares plummet on product recall|accessdate=22 June 2013}}
22. ^{{cite web|url=http://www.theaustralian.com.au/business/profit-loss/cochlear-reports-777m-h1-profit-as-it-recovers-from-recall/story-fn91vch7-1226570645539|publisher=The Australian|title=Cochlear reports $77.7m H1 profit as it recovers from recall|accessdate=22 June 2013}}

See also

  • Cochlear Bone Anchored Solutions AB
{{Business in Australia}}{{S&P/ASX 50}}

6 : Manufacturing companies based in Sydney|Companies listed on the Australian Securities Exchange|Medical technology companies of Australia|Hearing aid manufacturers|1981 establishments in Australia|Australian brands
随便看

　

开放百科全书收录14589846条英语、德语、日语等多语种百科知识，基本涵盖了大多数领域的百科知识，是一部内容自由、开放的电子版国际百科全书。

　

Copyright © 2023 OENC.NET All Rights Reserved
京ICP备2021023879号 更新时间：2024/9/23 0:44:00